ARRY @ Cantor Fitzgerald Global Healthcare Conf

Array BioPharma To Present At The 2017 Cantor Fitzgerald Global Healthcare Conference

BOULDER, Colo., Sept. 19, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the 2017 Cantor Fitzgerald Global Healthcare Conference.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   
Event:                         

Cantor Fitzgerald Global Healthcare Conference

Presenter:                   

Ron Squarer, Chief Executive Officer

Date:                           

Tuesday, September 26, 2017

Time:                          

8:35 a.m. Eastern Time

Webcast:                     

wsw.com/webcast/cantor6/arry/


About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).

CONTACT:      

Tricia Haugeto



Array BioPharma Inc.



303-386-1193



thaugeto@arraybiopharma.com